• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Celcuity Plans Phase 3 Gedatolisib Trial Secures 62M Debt Financing

    GLOBENEWSWIRE

    Celcuity Inc. Reports Fourth Quarter and Full Year 2023 Financial Results

    GLOBENEWSWIRE

    Celcuity Announces First Patient Dosed in Phase 1b/2 CELC-G-201 of Gedatolisib

    GLOBENEWSWIRE

    Celcuity Presents Data on Therapeutic Effects of Gedatolisib in Breast Cancer

    GLOBENEWSWIRE

    Celcuity to Present Preclinical Data for Gedatolisib

    GLOBENEWSWIRE

    Celcuity Presents Updated Results of Phase 1b Study of Gedatolisib

    ACCESSWIRE

    Celcuity Announces First Patient Dosed in PIII VIKTORIA-1 Trial of Gedatolisib

    ACCESSWIRE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.